I-Vault eTMF solution will be used to commence new Electronic Trial Master Files.
PharmaVigilant founder and chief executive officer James DeSanti said: "This implementation will automate monitoring of their TMF documentation and will provide Spectrum with an on-demand "dashboard" view of the their entire TMF inventory."
Spectrum is a pharmaceutical company that develops and commercializes a diversified portfolio of oncology and other drug candidates.
PharmaVigilant offers full suite of SaaS solutions that automate the collection, management and analysis of clinical trial data.